Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.420 | 0.650 | 0.230 |
Stocks | 99.580 | 99.580 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.972 | 19.420 |
Price to Book | 2.466 | 2.717 |
Price to Sales | 1.487 | 1.811 |
Price to Cash Flow | 11.167 | 13.858 |
Dividend Yield | 1.271 | 1.826 |
5 Years Earnings Growth | 11.158 | 12.178 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 37.710 | 14.293 |
Industrials | 21.020 | 37.093 |
Technology | 12.810 | 14.354 |
Consumer Defensive | 10.010 | 5.515 |
Real Estate | 7.190 | 11.137 |
Communication Services | 6.350 | 5.149 |
Consumer Cyclical | 1.810 | 7.751 |
Financial Services | 1.750 | 6.161 |
Basic Materials | 1.360 | 4.910 |
Number of long holdings: 37
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AAK | SE0011337708 | 7.09 | 323.0 | -0.31% | |
Ambea | SE0009663826 | 6.40 | 93.10 | +3.04% | |
MedCap | SE0009160872 | 6.31 | 403.000 | +9.81% | |
Lagercrantz B | SE0014990966 | 4.91 | 236.00 | +6.69% | |
Bufab Holding AB | SE0005677135 | 4.81 | 467.40 | +0.69% | |
Addtech | SE0014781795 | 4.54 | 324.40 | +1.31% | |
Tobii Dynavox AB | SE0017105620 | 4.37 | 74.80 | +2.47% | |
Xvivo Perfusion AB | SE0004840718 | 4.23 | 466.00 | -0.85% | |
Vimian Group AB | SE0015961982 | 4.19 | 40.65 | +0.74% | |
NCAB Group | SE0017160773 | 4.00 | 66.70 | -0.67% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Evli Global B SEK | 3.03B | 11.27 | 9.94 | 12.01 | ||
Evli Sweden Equity Index B | 2.69B | 6.22 | 3.36 | 8.37 | ||
Evli Swedish Small Cap A | 1.43B | 7.04 | -10.03 | 12.10 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review